Friday, April 23, 2021
wellness India Expo

“2021 holds a lot of promise for Novozymes”

774
In an exclusive interview with BioVoice, Krishna Mohan Puvvada – Regional President and Head, Consumer Biosolutions – India, Novozymes shared interesting insights on the latest activities, learnings from covid, future outlook and much more.................

COVAXIN demonstrates interim clinical efficacy of 78% in phase 3 trials

19
The second interim results showed India’s First COVID-19 Vaccine had demonstrated strong primary efficacy against severe COVID-19 disease.......................

COVID19 survivors reporting neurological & mental health issues

16
Neurocognitive testing, psychiatric evaluation, and diagnostic imaging of COVID19 survivors should be continued for at least six months even after recovery, writes Dr Dhanashri Chonkar............................

Less than 4% Indian farmers have adopted sustainable agricultural practices: CEEW

35
The study, supported by the Food and Land Use Coalition (FOLU), finds that scaling up sustainable agriculture would be critical to improve farm incomes and bolster India’s nutrition security in a climate-constrained future...........................

MOST READ ARTICLES

Face to Face

“We will venture into newer therapy areas, expect to launch an...

300
Luca Visini, Managing Director, Eli Lilly & Company India shares his views on a variety of questions related to the company's operations in an exclusive interaction with BioVoice....................

Chat with BioVoice

“Sukino is India’s first comprehensive continuum care provider”

149
In an exclusive interview with BioVoice, Rajinish Menon, Founder and Chief Executive Officer, Sukino Healthcare, shared the company's foundational story, his views on the concept of Continuum Care in India, revenue model, growth drivers, and future outlook...............

R&D

Events